List of insiders holdings for RECURSION PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Mubadala Investment Co PJSC Mamoura Diversified Global Holding PJSC 10% Owner |
2023-03-03 16:09:13 | 0 20,048,796 |
20,048,796 | Form 4 |
| 2 | Lux Ventures IV L.P. Lux Venture Partners IV LLC Lux Co-Invest Opportunities L.P. Lux Co-Invest Partners LLC Hebert Peter Wolfe Josh Former 10% Owner |
2021-12-09 20:57:21 | 17,287,095 0 |
17,287,095 | Form 4 |
| 3 | Bogue Zachary Director 10% Owner |
2023-07-06 18:04:26 | 9,378 13,619,224 |
13,628,602 | Form 4 |
| 4 | Data Collective IV L.P. Data Collective IV GP LLC DCVC V GP LLC DCVC V L.P. DCVC Opportunity Fund II GP LLC DCVC Opportunity Fund II L.P. Ocko Matthew 10% Owner |
2022-02-14 15:23:34 | 13,619,224 0 |
13,619,224 | Form 13G |
| 5 | Gibson Christopher Chief Executive Officer |
2025-03-28 16:52:57 | 10,232,153 941,875 |
11,174,028 | Form 4 |
| 6 | Borgeson Blake Director |
2025-01-06 18:02:30 | 7,067,847 0 |
7,067,847 | Form 4 |
| 7 | Secora Michael Chief Financial Officer |
2024-11-19 18:26:27 | 3,384,341 0 |
3,384,341 | Form 4 |
| 8 | Li Dean Y Director |
2025-04-03 16:37:52 | 79,618 3,112,844 |
3,192,462 | Form 4 |
| 9 | Marriott Tina President and COO |
2024-11-19 18:26:17 | 2,154,901 0 |
2,154,901 | Form 4 |
| 10 | Khan Najat Chief R&D Commercial Officer |
2025-02-05 16:50:30 | 2,126,551 0 |
2,126,551 | Form 4 |
| 11 | Taylor Ben R Chief Financial Officer |
2025-04-03 16:38:14 | 2,116,561 0 |
2,116,561 | Form 4 |
| 12 | MIC Capital Partners (Public) Parallel Cayman LP MIC Capital Management UK LLP MIC CAPITAL PARTNERS (PUBLIC) (US) IM LLC 10% Owner |
2021-11-03 16:50:12 | 0 1,388,889 |
1,388,889 | Form 3/A |
| 13 | Virani Shafique Chief Business Officer |
2024-01-18 18:39:02 | 796,610 0 |
796,610 | Form 4 |
| 14 | Mauro David J Chief Medical Officer |
2024-11-19 18:26:37 | 706,392 0 |
706,392 | Form 4 |
| 15 | Michor Franziska Director |
2024-11-22 18:25:51 | 251,468 0 |
251,468 | Form 4 |
| 16 | Doyle Ramona Chief Medical Officer |
2022-05-18 19:19:17 | 121,110 0 |
121,110 | Form 4 |
| 17 | Dar Zavain Director |
2025-04-03 16:37:01 | 110,877 0 |
110,877 | Form 4 |
| 18 | Sun Elaine D Director |
2025-03-19 16:27:16 | 109,648 0 |
109,648 | Form 4 |
| 19 | Bumpus Namandje Director |
2025-03-19 16:27:28 | 109,648 0 |
109,648 | Form 4 |
| 20 | HERSHBERG ROBERT Director |
2024-06-05 18:12:17 | 77,909 0 |
77,909 | Form 4 |
| 21 | Burrell Terry-Ann Director |
2024-07-03 16:39:43 | 71,254 0 |
71,254 | Form 4 |
| 22 | CHAVEZ R. MARTIN Director |
2024-04-03 17:43:13 | 60,078 0 |
60,078 | Form 4 |
| 23 | MIC CAPITAL PARTNERS (PUBLIC) (US) IM LLC See remarks |
2021-11-03 17:17:13 | 0 0 |
0 | Form 4 |